| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00115-005-1925-6 |
| P698 | PubMed publication ID | 15931537 |
| P50 | author | Siegfried Kasper | Q2283474 |
| Nilufar Mossaheb | Q50577329 | ||
| P2093 | author name string | G. P. Amminger | |
| G. Wiesegger | |||
| J. Tauscher | |||
| P2860 | cites work | The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design | Q28185278 |
| The positive and negative syndrome scale (PANSS) for schizophrenia | Q28301751 | ||
| The neuropathology of schizophrenic diseases: historical aspects and present knowledge | Q31477058 | ||
| Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia | Q33179595 | ||
| Early course of illness in first episode schizophrenia with long duration of untreated illness - a comparative study | Q33197575 | ||
| First-episode schizophrenia: the importance of early intervention and subjective tolerability. | Q33810959 | ||
| Meta-analysis of regional brain volumes in schizophrenia | Q33885349 | ||
| Diagnosing schizophrenia in the initial prodromal phase | Q33933362 | ||
| Schizophrenia as a disorder of neurodevelopment | Q34132313 | ||
| Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms | Q34153146 | ||
| Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature | Q34166972 | ||
| Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia | Q34167569 | ||
| Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia | Q60796188 | ||
| Patterns of premorbid functioning in first-episode psychosis: initial presentation | Q60998116 | ||
| Pathways to care: help seeking behaviour in first episode psychosis | Q61002903 | ||
| Premorbid neuropathology in schizophrenia | Q69922373 | ||
| Prenatal disturbances of nerve cell migration in the entorhinal region: a common vulnerability factor in functional psychoses? | Q70196792 | ||
| The concept of substrate-close basic symptoms and its significance for the theory and therapy of schizophrenic diseases | Q72551739 | ||
| The course of schizophrenia in the light of modern follow-up studies: the ABC and WHO studies | Q73399884 | ||
| Predictors and outcome characteristics associated with suicidal behaviour in early psychosis: a two-year follow-up of first-admitted subjects | Q73941963 | ||
| Randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high-risk individuals. Study design and interim analysis of transition rate and psychological risk factors | Q77074145 | ||
| Relationship between childhood behavioral disturbance and later schizophrenia in the New York High-Risk Project | Q77316461 | ||
| Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity | Q78033198 | ||
| Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. | Q34174069 | ||
| New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis | Q34196968 | ||
| Duration of untreated psychosis: a critical examination of the concept and its importance | Q34220976 | ||
| Oligodendrocyte dysfunction in schizophrenia and bipolar disorder | Q34246905 | ||
| Early intervention for first episodes of schizophrenia: a preliminary exploration | Q34372735 | ||
| The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches | Q34463416 | ||
| Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States | Q34475129 | ||
| Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia | Q34515196 | ||
| Community-based mental health care: to what extent are service costs associated with clinical, social and service history variables? | Q34653841 | ||
| The New York high risk project to the Hillside recognition and prevention (RAP) program | Q35011820 | ||
| Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences | Q35182105 | ||
| Early detection and intervention in the initial prodromal phase of schizophrenia | Q35608266 | ||
| Early psychosis in the inner city: a survey to inform service planning | Q39592834 | ||
| Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome | Q40568751 | ||
| The quantity and quality of the social networks of young people with early psychosis compared with closely matched controls | Q40736421 | ||
| Prediction of psychosis. A step towards indicated prevention of schizophrenia. | Q40840671 | ||
| Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): efficacy and tolerability results of an international naturalistic study | Q43679583 | ||
| A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia | Q43812686 | ||
| A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year | Q43999469 | ||
| Atypical neuroleptics stimulate neurogenesis in adult rat brain | Q44059818 | ||
| Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia | Q44118975 | ||
| An integration of schizophrenia with schizotypy: identification of schizotaxia and implications for research on treatment and prevention | Q45712750 | ||
| Relationship between premorbid functioning and symptom severity as assessed at first episode of psychosis | Q47566883 | ||
| Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study | Q48280427 | ||
| Developmental abnormalities of the hippocampus in first-episode schizophrenia. | Q48343135 | ||
| Non-reduction in hippocampal volume is associated with higher risk of psychosis | Q48457063 | ||
| Temporal lobe volume changes in people at high risk of schizophrenia with psychotic symptoms. | Q48526279 | ||
| The temporal lobe in schizophrenia from uni- and multiply affected families. | Q48599636 | ||
| Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. | Q50790918 | ||
| A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. | Q51952067 | ||
| Comparing patterns and costs of schizophrenia care in five European countries: the EPSILON study. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs. | Q51955813 | ||
| The schizophrenia prodrome: treatment and high-risk perspectives. | Q51959634 | ||
| Factors that influence the cost of caring for patients with severe psychotic illness: report from the UK 700 trial. | Q51967196 | ||
| Duration of untreated psychosis predicts treatment outcome in an early psychosis program. | Q51968191 | ||
| The epidemiology of onset and course of schizophrenia. | Q51970650 | ||
| Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses. | Q52002345 | ||
| Early self-experienced neuropsychological deficits and subsequent schizophrenic diseases: an 8-year average follow-up prospective study. | Q52042982 | ||
| Does treatment delay in first-episode psychosis really matter? | Q55036321 | ||
| Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia | Q57739219 | ||
| The prevalence of prodromal features of schizophrenia in adolescence: a preliminary survey | Q57998245 | ||
| The Influence of Age and Sex on the Onset and Early Course of Schizophrenia | Q58897412 | ||
| Causes and consequences of duration of untreated psychosis in schizophrenia | Q59784190 | ||
| Early intervention in schizophrenia | Q60643246 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 23-34 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Der Nervenarzt | Q15446312 |
| P1476 | title | Früherkennung und Frühintervention der Schizophrenie | |
| P478 | volume | 77 |
| Q36827239 | Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia? | cites work | P2860 |
Search more.